U
U.S. pharmaceutical company developing proprietary advanced drug-delivery systems for psychedelic and other active pharmaceutical ingredients. Its technologies include transdermal patches and oral-mucosal delivery, with research targeting mental health, cancer-related conditions, and cognitive degenerative diseases. The company reports an IP-protected sustained microdosing approach and preclinical development of psilocybin and ketamine delivery candidates.